Literature DB >> 25964596

Predictors of intrahepatic multiple recurrences after curative hepatectomy for hepatocellular carcinoma.

Kazuki Takeishi1, Takashi Maeda2, Eiji Tsujita2, Yo-Ichi Yamashita3, Noboru Harada2, Shinji Itoh4, Norifumi Harimoto4, Toru Ikegami4, Tomoharu Yoshizumi4, Ken Shirabe4, Yoshihiko Maehara4.   

Abstract

BACKGROUND/AIM: Survival of patients with multiple recurrences (MR) of hepatocellular carcinoma (HCC) is very poor as recurrent tumors are usually aggressive and not amenable to curative resection. The present study aimed to investigate retrospectively predictors of intrahepatic MR of HCC after hepatectomy. PATIENTS AND METHODS: We reviewed 416 patients who underwent hepatectomy and developed intrahepatic recurrence during the follow-up period. According to the recurrence pattern, the patients were divided into two groups: 83 who had four or more recurrent lesions in the remnant liver were defined as the MR group and the others who constituted the control group.
RESULTS: Multivariate analysis showed that micro-intrahepatic metastasis, α-fetoprotein and tumor size were independent risk factors for MR after hepatectomy. The combination of these three independent factors was significantly associated with MR. The recurrence rates within 1 year after hepatectomy of MR and control groups were 53.0% and 27.6%, respectively (p=0.0001). The 5-year overall survival rate of the MR group was 39%, which was significantly less than that of the control group (68%, p<0.0001).
CONCLUSIONS: MR of HCC was associated with an earlier recurrence and poorer survival after hepatectomy. The combination of three independent factors for MR might help predict MR occurrence during the follow-up period. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; hepatectomy; multiple recurrences

Mesh:

Year:  2015        PMID: 25964596

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  Impact of Splenic Volume and Splenectomy on Prognosis of Hepatocellular Carcinoma Within Milan Criteria After Curative Hepatectomy.

Authors:  Kazuki Takeishi; Hirofumi Kawanaka; Shinji Itoh; Norifumi Harimoto; Toru Ikegami; Tomoharu Yoshizumi; Ken Shirabe; Yoshihiko Maehara
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

2.  The Prognostic Impact of Tumor Differentiation on Recurrence and Survival after Resection of Hepatocellular Carcinoma Is Dependent on Tumor Size.

Authors:  Hiroji Shinkawa; Shogo Tanaka; Daijiro Kabata; Shigekazu Takemura; Ryosuke Amano; Kenjiro Kimura; Masahiko Kinoshita; Shoji Kubo
Journal:  Liver Cancer       Date:  2021-08-24       Impact factor: 11.740

3.  Detection of CTNNB1 Hotspot Mutations in Cell-Free DNA from the Urine of Hepatocellular Carcinoma Patients.

Authors:  Selena Y Lin; Ting-Tsung Chang; Jamin D Steffen; Sitong Chen; Surbhi Jain; Wei Song; Yih-Jyh Lin; Ying-Hsiu Su
Journal:  Diagnostics (Basel)       Date:  2021-08-14

4.  Sorafenib and a novel immune therapy in lung metastasis from hepatocellular carcinoma following hepatectomy: A case report.

Authors:  Yongxiang Yi; Jianbo Han; Yuan Fang; Dongxiao Liu; Zuoyou Wu; Lili Wang; Liang Zhao; Qiang Wei
Journal:  Mol Clin Oncol       Date:  2016-06-10

5.  New Developments in the Treatment of Hepatocellular Carcinoma: The Concept of Adjuvant and Neoadjuvant Chemotherapy.

Authors:  Anil C Anand; Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2021-04-27

6.  A comparison of the risk factors of intrahepatic recurrence, early recurrencen, and multiple recurrences after resection for single nodular hepatocellular carcinoma.

Authors:  Hyun Joon An; Woo Young Shin; Keon-Young Lee; Seung-Ik Ahn
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2015-08-28

7.  Expression and Significances of G-Protein-Coupled Receptor Kinase 3 in Hepatocellular Carcinoma.

Authors:  Ye Jin; Zhi-Yong Liang; Wei-Xun Zhou; Li Zhou
Journal:  J Cancer       Date:  2017-07-05       Impact factor: 4.207

8.  CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity.

Authors:  Ruo-Yu Chen; Chia-Jui Yen; Yao-Wen Liu; Chun-Guo Guo; Chieh-Yu Weng; Chien-Hsien Lai; Ju-Ming Wang; Yih-Jyh Lin; Liang-Yi Hung
Journal:  Cell Death Differ       Date:  2019-09-11       Impact factor: 15.828

9.  Establishment of an Immunocompetent Metastasis Rat Model with Hepatocyte Cancer Stem Cells.

Authors:  Semon Wu; I-Chieh Tseng; Wen-Cheng Huang; Cheng-Wen Su; Yu-Heng Lai; Che Lin; Alan Yueh-Luen Lee; Chan-Yen Kuo; Li-Yu Su; Ming-Cheng Lee; Te-Cheng Hsu; Chun-Hsien Yu
Journal:  Cancers (Basel)       Date:  2020-12-11       Impact factor: 6.639

Review 10.  Neoadjuvant Therapy for Hepatocellular Carcinoma.

Authors:  Zongyi Yin; Dongying Chen; Shuang Liang; Xiaowu Li
Journal:  J Hepatocell Carcinoma       Date:  2022-08-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.